Esophageal Cancer in a Hereditary Hemorrhagic Telangiectasia Patient
View/
Issue Date
2020-02-18Article Version
Scholarly/refereed, publisher version
Metadata
Show full item recordAbstract
Hereditary hemorrhagic telangiectasia (HHT) is a disorder characterized by vascular manifestations including mucocutaneous and visceral telangiectasias and arteriovenous malformations. Herein we present the case of a relatively young patient with HHT with an incidentally discovered locally advanced esophageal cancer on endoscopic screening and pathologically complete response after neoadjuvant chemoradiation. This case highlights an unusual tumor response to chemoradiation in locally advanced esophageal cancer, and the surveillance care of HHT patients.
Description
The final, published version of this article is available at http://www.karger.com/?doi=10.1159/000505832A grant from the One-University Open Access Fund at the University of Kansas was used to defray the author's publication fees in this Open Access journal. The Open Access Fund, administered by librarians from the KU, KU Law, and KUMC libraries, is made possible by contributions from the offices of KU Provost, KU Vice Chancellor for Research & Graduate Studies, and KUMC Vice Chancellor for Research. For more information about the Open Access Fund, please see http://library.kumc.edu/authors-fund.xml.
Collections
Citation
Park R, Philp A, Nagji A, S, Kasi A: Pathologically Complete Response after Triple Therapy in Locally Advanced Esophageal Cancer in a Hereditary Hemorrhagic Telangiectasia Patient. Case Rep Oncol 2020;13:176-181. doi: 10.1159/000505832
Items in KU ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Except where otherwise noted, this item's license is described as: © 2020 The Author(s). Published by S. Karger AG, Basel. This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
